NCT06816147

Brief Summary

This pilot study will focus on men and women aged ≥60 years for a period of 3 months during which each participant will use the HLRS. The primary purpose is to study whether the HLRS, reflecting a multi-component intervention, is well accepted by the participant, has a decent adherence (i.e., user time of the app). In addition, investigators will study the feasibility of the design, i.e. whether the overall design is well suited to the participants, in order to improve their lifestyle, e.g., dietary habits and PA, among others. Secondary outcomes related to the feasibility approach include dietary habits, PA patterns, and selected plasma and urinary endpoints. This pilot study will be of longitudinal design without a control group. A later trial that is planned for the following year will focus further on biological endpoints and will be randomized. In this present pilot study, investigators aim to assess mainly the user-friendliness of the HLRS, and gather first evidence that the intervention can indeed produce healthier lifestyle patterns. The study's primary objective is to determine whether the developed HLRS can be successfully applied to the target population (men and women aged ≥60 years) and whether they use it frequently during the study and are satisfied with the HLRS. Secondly, investigators will study whether the assessment of endpoints required for the later and separately planned ensuing long-term study can be well assessed within the study and if, despite the limited time of the intervention duration, the intervention will be able to preliminary improve specific markers related to the risk of obesity and associated comorbidities. This will entail anthropometric measures to assess changes in body mass and body fat in addition to the primary and secondary objectives.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
7mo left

Started Nov 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress51%
Nov 2025Dec 2026

First Submitted

Initial submission to the registry

December 5, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 10, 2025

Completed
9 months until next milestone

Study Start

First participant enrolled

November 19, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

December 12, 2025

Status Verified

September 1, 2025

Enrollment Period

11 months

First QC Date

December 5, 2024

Last Update Submit

December 5, 2025

Conditions

Keywords

ObesityBMIoverweightlife style recommender solution

Outcome Measures

Primary Outcomes (2)

  • Health Lifestyle Recommender System adherence time

    Adherence time (daily and weekly usage time in minutes) will be measured by tracking through user log-data, with analysis of any significant changes in usage comparing baseline with final measurement.

    3 month intervention period from baseline (Day 1) to final measurement (Day 90)

  • Health Lifestyle Recommender system user experience

    User experience corresponds to the points achieved in the User Experience Questionnaire (UEQ+, 26 items). This questionnaire analyses the attractiveness, perspicuity, efficiency, dependability, stimulation and novelty of a new product (in this case HLRS). The UEQ contains 26 items. Each item is evaluated with a 7-point Likert scale (-3 to 3 points). Then the product is classified as excellent (3 points) or bad (-3 points).

    3 month intervention period from baseline (Day 1) to final measurement (Day 90)

Secondary Outcomes (33)

  • Anthropometric measurements (1/4)

    3 month intervention period from baseline (Day 1) to final measurement (Day 90)

  • Anthropometric measurements (2/4)

    3 month intervention period from baseline (Day 1) to final measurement (Day 90)

  • Anthropometric measurements (3/4)

    3 month intervention period from baseline (Day 1) to final measurement (Day 90)

  • Anthropometric measurements (4/4)

    3 month intervention period from baseline (Day 1) to final measurement (Day 90)

  • Physical activity and fitness (1/4)

    3 month intervention period from baseline (Day 1) to final measurement (Day 90)

  • +28 more secondary outcomes

Study Arms (1)

Participant from the general population living in Luxembourg free of manifest diagnosed diseases

EXPERIMENTAL

The following clinical visits and data collection points will be set up within the study: 1. Enrollment visit: the participant will sign the informed consent, the eligibility of the participant will be evaluated based on anthropometric measures, a urine spot sample, as well as general questionnaire. If found eligible, the participant can continue the study 2. Baseline visit: a number of questionnaires will be filled out by the participant, anthropometric data will be obtained, and a urine and blood sample will be taken, and a stool sample will be provided 3. Intermediate follow-up: this will consist of a phone interview or physical meeting 4. Final visit: a number of questionnaires will be filled anthropometric data, urine, blood and stool will be collected

Other: Investigators will evaluate the acceptance and adherence to a healthy lifestyle recommender solution (HLRS), a digital app, among participants

Interventions

The intervention will include collecting blood, stool, urinary samples as well as measuring anthropometrics and collecting data (socio-demographics, general health, well-being, PA, and eating patterns, among others) via questionnaires completed in part from a mobile application.

Participant from the general population living in Luxembourg free of manifest diagnosed diseases

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals aged 60 or older:
  • both males/females, general free-living population,
  • residing in Luxembourg,
  • having normal weight or being overweight, i.e., with a BMI between 18.5 ; 30 kg/m², which is considered a risk factor for developing obesity,
  • owning a smartphone.

You may not qualify if:

  • With known manifest chronic diseases that prohibits participation in the study (e.g., cancer, Parkinson's),
  • Persons with cognitive diseases (Alzheimer's) or those who are not able to lead an independent life,
  • Persons following a strict diet (on their own or advised by their physician),
  • Particular population groups, such as prisoners, the mentally disabled, or groups whose ability to give voluntary informed consent may be in question.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinical and Epidemiological Investigation Center CIEC- LCTR

Luxembourg, L-1445, Luxembourg

RECRUITING

MeSH Terms

Conditions

ObesityOverweight

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Torsten Bohn PhD, Adjunct Associate Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: The project is a pilot study. It is a single-group study where participants will be their own control (i.e. outcome measures at the end of study will be compared to baseline). 30 participants will be included. It consists of samples and data collection, together with a mobile application that allows dispensing an intervention that will last 3 months. This pilot study will be longitudinal design without a control group. A later trial that is planned for the following year will focus further on biological endpoints and will be randomized. In this present pilot study, investigators aim to assess mainly the user-friendliness of the HLRS, and gather first evidence that the intervention can indeed produce healthier lifestyle patterns. Should the participants complete the study, the individual duration will be 3 months. Investigators foresee that, in total, given the various enrolments of the participants, up to 6 months may be necessary for all participants to complete the entire study.
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 5, 2024

First Posted

February 10, 2025

Study Start

November 19, 2025

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

December 12, 2025

Record last verified: 2025-09

Locations